Today: 5 April 2026
Subscribe
Browse Category

Stock Market 1 October 2025 - 2 October 2025

SoFi Stock Plunges on September 30 – What’s Going On?

SoFi Technologies (SOFI) Stock Report — Oct 1 2025: Is the Fintech Rocket Starting to Cool?

SoFi shares closed at $25.76 on Oct. 1, down 2.5% amid heavy trading and a multi-day slide. The company reported $3.03 billion in trailing 12-month revenue and net income of $561.6 million, with a market cap near $30.85 billion. SoFi serves 11.7 million members and faces rising customer acquisition costs and $3.94 billion in debt. Its third-quarter earnings call is set for Oct. 28.
2 October 2025
··
Oura Ring 4 Ceramic Collection: Why This Stylish Health Wearable Could Revolutionize Your Self‑Tracking

Oura Ring 4 Ceramic Collection: Why This Stylish Health Wearable Could Revolutionize Your Self‑Tracking

Oura launched the Ring 4 Ceramic, made from zirconia ceramic with a Mohs hardness of 8.5, priced at $499. The ring features improved sensors with 30% better SpO₂ accuracy, lasts 5–8 days per charge, and is water-resistant to 100 meters. A $99 portable charging case and multi-ring account support are also available. Oura now offers a $99 blood-test service through Quest Diagnostics for U.S. users.
1 October 2025
Elon Musk Smashes Records by Hitting $500 Billion Net Worth—How He Got There and What It Means

Elon Musk Smashes Records by Hitting $500 Billion Net Worth—How He Got There and What It Means

Elon Musk’s fortune topped $500 billion on Oct. 1, 2025, after Tesla shares jumped nearly 4%, making him the first person to reach that mark, according to Forbes. Tesla’s board proposed a $1 trillion, 10-year pay package for Musk and approved an interim $29 billion stock grant. SpaceX is projected to earn $15.5 billion in 2025 with 170 launches. Musk stepped down as head of the Trump administration’s “Department of Government Efficiency” in May.
1 October 2025
··
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

U.S. stocks closed at record highs despite a partial government shutdown, with the S&P 500 up 0.34% to 6,711.20 and the Dow rising 0.09% to 46,441.10. Health-care shares jumped after Pfizer and the White House struck a drug price deal, sending Biogen up 10.9%. The ADP report showed private-sector jobs fell by 32,000 in September, but investors bet on Fed rate cuts.
1 October 2025
·····
ACM Research (ACMR) at October 1 2025: Surging Backlog, Index Inclusion and a Market Shake‑up—What’s Next for the Semiconductor Equipment Innovator?

ACM Research (ACMR) at October 1 2025: Surging Backlog, Index Inclusion and a Market Shake‑up—What’s Next for the Semiconductor Equipment Innovator?

ACM Research (Shanghai) reported a backlog of RMB 9.07 billion (US$1.27 billion) as of Sept 29, up 34.1% year-over-year. In August, the company raised ¥4.5 billion (~US$630 million) in a private placement, reducing ACM Research’s stake in the subsidiary to 74.5%. ACMR joined the S&P SmallCap 600 Index on Sept 26. Q2 2025 revenue rose 6.4% to $215.4 million, with net income of $29.8 million.
1 October 2025
···
Natural Gas Prices Soar: Will America’s Energy Boom Fuel a New Price Spike in 2026?

Natural Gas Prices Soar: Will America’s Energy Boom Fuel a New Price Spike in 2026?

U.S. natural-gas futures rose to $3.47/MMBtu on October 1, 2025, up 5% from the previous day and 20% year-on-year. Lower-48 production slipped to 107.4 bcf/d in September, while storage remained 6% above the five-year average. Trading Economics projected prices to reach $4.15/MMBtu within a year. U.S. LNG export capacity is set to grow 36% from 2024 to 2026 as new terminals open.
1 October 2025
·····
Undervalued Oil Explorer Ready to Erupt? Why Pharos Energy’s New Egyptian Deal and Rising Production Could Trigger a Massive Share‑Price Surge! /updated: 3:00 PM EDT/

Undervalued Oil Explorer Ready to Erupt? Why Pharos Energy’s New Egyptian Deal and Rising Production Could Trigger a Massive Share‑Price Surge! /updated: 3:00 PM EDT/

Pharos Energy reported group production of 5,642 boe/d in 1H 2025, with revenue of $65.6 million and a net loss of $2.2 million. The company operates in Vietnam and Egypt and paid a 0.363 p/share interim dividend in January. Shares closed at 21.40 pence on Oct. 1, down about 12% year-to-date. Market cap stood at £86 million, with analysts’ consensus rating at Buy.
1 October 2025
···
MainStreet Bancshares (MNSB): Small Bank, Big Moves — Why Investors Are Buzzing /updated: 3:00 PM EDT/

MainStreet Bancshares (MNSB): Small Bank, Big Moves — Why Investors Are Buzzing /updated: 3:00 PM EDT/

MainStreet Bancshares shares traded near $20.50 on Oct. 1, 2025, with a market cap of about $162 million and a forward P/E of 11.3. Q2 2025 net income rose to $4.6 million, beating forecasts, as EPS doubled to $0.53. Institutional investors hold roughly 53% of shares. Wendy Adeler Hall joins the board Oct. 16; two directors received restricted stock grants at $20.83 per share.
1 October 2025
·
Fluence Energy (FLNC) Skyrockets on Mega Battery Deal – Inside the Rally and What’s Next

Fluence Energy (FLNC) Skyrockets on AI Hype and Storage Deals – Can the Rally Last? /updated: 3:00 PM EDT/

FLNC surged 11% to $12.03 on Oct. 1, 2025, capping a two-week run that doubled its share price. Q3 revenue rose 24.7% to $602.7M with net income of $6.9M, but full-year guidance was cut due to project delays. The company secured major storage contracts in Poland and Ukraine and opened a 35 GWh battery plant in Vietnam. Analyst consensus remains Hold, with a $8.13 average price target.
1 October 2025
····
AES Corp Stock Skyrockets as BlackRock Nears $38B Takeover – What Investors Need to Know /updated: 3:00 PM EDT/

AES Corp Stock Skyrockets as BlackRock Nears $38B Takeover – What Investors Need to Know /updated: 3:00 PM EDT/

AES shares closed at $15.34 on Oct. 1, up 16.6% after reports that BlackRock’s GIP is in talks to acquire the company for about $38 billion including debt. The stock led S&P 500 gains following the news. AES’s market cap stands at $9.4 billion, with debt near $29 billion. Eleven analysts rate AES a “Moderate Buy,” with an average 12-month price target of $24.67.
1 October 2025
···
Rick Perry’s $15B Data Center Dream Goes Public in AI Gold Rush

Rick Perry’s $15B Data Center Dream Goes Public in AI Gold Rush

Fermi America raised $682.5 million in its September 2025 IPO, valuing the AI infrastructure startup at up to $15 billion. Shares opened nearly 19% higher on Nasdaq, with a London listing following. The company plans a 5,000-acre AI campus near Amarillo, Texas, aiming to deliver up to 11 GW of power. Co-founded by Rick Perry, Fermi is pre-revenue and seeking federal loans and reactor approvals.
1 October 2025
····
QuantumScape 2025: Latest News, Solid-State Battery Breakthroughs, Financials & Outlook (June 27th, 2025)

QuantumScape Shares Soar on Corning Deal – Is Solid-State Battery Tech Finally Taking Off?

QuantumScape shares surged 12.9% to close at $13.91 on Oct. 1, with volume topping 47 million. The move followed a strategic partnership with Corning and a live Ducati demo using QSE-5 solid-state batteries. Market cap ranged from $7.0–8.3 billion. Most analysts rate the stock Hold, with average price targets near $6–$7.
1 October 2025
·····
Nike Stock Skyrockets After Earnings Beat – Experts Weigh In

Nike Inc (NKE) Stock Soars 5.7% on Oct 1, 2025: Tariff Headwinds, Turnaround & Analyst Buzz

Nike shares jumped 5.7% to $73.60 on Oct. 1, 2025, after Q1 results beat forecasts, with trading volume surging to 25.2 million. Q1 revenue rose 1% to $11.72 billion and EPS hit $0.49, but gross margin slipped to 42.2%. Year-to-date, the stock is down 2.7%, trailing the S&P 500’s 13% gain. Wall Street rates Nike a Moderate Buy, with targets ranging from $58 to $115.
1 October 2025
··
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Surges on Obesity-Drug Boom – Is $1,000 Next?

Eli Lilly shares surged nearly 9% to $832 intraday on Oct. 1 after closing at $763 on Sept. 30, driven by bullish options activity and optimism over its weight-loss and Alzheimer’s drugs. Q2 revenue jumped 38% to $15.56 billion, powered by GLP-1 treatments Mounjaro and ZepBound. The company raised full-year sales guidance to $60–$62 billion. Lilly faces a lawsuit from Texas over alleged incentives for prescriptions, which it denies.
1 October 2025
·
Xbox Game Pass Just Changed Everything: 50% Price Hike, New Plans, and 75+ Day-One Games

Xbox Game Pass Just Changed Everything: 50% Price Hike, New Plans, and 75+ Day-One Games

Microsoft raised Xbox Game Pass Ultimate to $29.99/month, a 50% increase, and rebranded Core and Standard as Essential ($9.99) and Premium ($14.99). All tiers now include expanded game libraries and cloud access. Ultimate adds Fortnite Crew, Ubisoft+ Classics, and up to $100 in store credit yearly. Over 45 new games, including Hogwarts Legacy, launched on Game Pass today.
1 October 2025
·
BlackRock’s GIP Poised for $38B AES Power Grab – AI-Fuelled Demand Sparks Takeover Frenzy

BlackRock’s GIP Poised for $38B AES Power Grab – AI-Fuelled Demand Sparks Takeover Frenzy

BlackRock’s Global Infrastructure Partners is in advanced talks to acquire AES Corp. for about $38 billion including debt, according to sources cited by the Financial Times and Bloomberg. AES shares surged 14% in pre-market trading on October 1, 2025, following news of the potential deal. Neither BlackRock nor AES has commented. The deal could be announced imminently but is not yet final.
1 October 2025
···
Rezolve AI Stock Skyrockets on 426% Revenue Surge – Can $7+ Targets Hold?

Rezolve AI Stock Skyrockets on 426% Revenue Surge – Can $7+ Targets Hold?

Rezolve AI (NASDAQ:RZLV) reported H1 2025 revenue of $6.3 million, up 426% year-over-year, beating estimates and raising its 2025 ARR guidance to $150 million. The company completed two Q3 financings totaling $250 million, ending September with $230 million in cash. RZLV shares jumped over 20% pre-market on Oct. 1 after earnings, with analysts raising price targets to $8.50–$9.00.
1 October 2025
···
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit’s Stock RDDT Rockets 600%: AI Deals, Big Earnings, and Wall Street Forecasts

Reddit (NYSE:RDDT) closed at $230 on Sept. 30, down from a mid-September peak near $283, but up 245% year-to-date. Q2 2025 revenue hit $500M (+78% YoY) with net income of $89M, beating guidance. Daily active uniques reached 110 million, up 21% YoY. Analysts’ 12-month price targets average $201–202, with RDDT trading at ~24× sales and a trailing P/E near 200.
1 October 2025
··
Motorola’s Next Phone Will Blow Your Mind – It’s Crazy Thin! Motorola’s Ultra-Thin Edge 70 and X70 Air Signal a New Smartphone War

Motorola’s Next Phone Will Blow Your Mind – It’s Crazy Thin! Motorola’s Ultra-Thin Edge 70 and X70 Air Signal a New Smartphone War

Motorola confirmed the Moto X70 Air will launch in China by October 2025, with a global Edge 70 variant expected late 2025 or early 2026. Leaked images show an ultra-thin, flat design in green and gray, with yellow camera accents and a 50MP ultra-wide camera. The phone will use Qualcomm’s Snapdragon 8 Gen 5 chip and feature AI tools. Motorola markets the device as both “impossibly thin” and durable.
1 October 2025
···
1 … 1,343 1,344 1,345 1,346 1,347 … 1,371

Stock Market Today

  • Ocugen (OCGN) Shows Strong Momentum Amid Gene Therapy Pipeline Developments
    April 5, 2026, 1:25 AM EDT. Ocugen's (OCGN) stock displayed notable volatility recently with a 30-day return of 11.18% and a 1-year gain of 170.39%, signaling growing momentum. Trading at $1.79, its share price remains well below analysts' average target of $11.57, reflecting optimism about its late-stage gene therapy candidates like OCU400 and OCU410. These therapies target large, unmet medical needs and could drive substantial future revenue. However, reliance on unapproved treatments and ongoing cash burn presents risks, with trial setbacks or funding shortfalls potentially impacting valuations. Investors are encouraged to consider both growth potential and key warning signs before positioning in OCGN shares.
Go toTop